Naloxo-X Injection
0.40mg

Naloxo-X

Naloxo-X Injection

Naloxone

Bajwa Pharmaceuticals (Pvt.) Ltd.

Drug Identity

Active Ingredient
Naloxone
Drug Class
All Other Therapeutic Products, Antidotes
ATC Code
A06AH04, V03AB15
Status
Essential Medicine

What is Naloxo-X?

Uses
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL ) in combination with lenalidomide that is relapsed or refractory (r/r), or...

How It Works

To be administered by IV, IM or SC injection. The most rapid onset of action is achieved with IV use, which is recommended in emergency situations. Titrate the administration rate in accordance with the patients response. Dilute in NS or D5W solutions. The addition of 2 mg in 500 ml of either solution provides a concentration of 0.004 mg/ml.

How to Take It

Dosage information not available for this product.

Safety Alerts

Before you receive Monjuvi, tell your healthcare provider about all of your medical conditions, including if you: have an active infection or have had one recently are pregnant or plan to become pregnant are breastfeeding or plan to breastfeed

Important Warnings

Cardiovascular disease or those receiving cardiotoxic drugs (risk of serious adverse cardiovascular effects), maternal physical dependence on opioids (may precipitate withdrawal in newborn), pain, physical dependence on opioids (precipitates withdrawal), pregnancy except in labour, keep patient under observation as repeat doses may be needed

Side Effects

Agitationcardiac arrestheadachedizzinessdyspnoea (in children)hypertensionhyperventilationhypotensionnauseapulmonary oedematachycardiaventricular fibrillationvomitingarrhythmiabradycardia

Drug Interactions

Other drugs may interact with Monjuvi
including prescription and over-the-counter medicines
vitamins
and herbal products . Tell your healthcare provider about all the medicines you take
including prescription and over-the-counter medicines
vitamins
and herbal supplements.

Pregnancy & Lactation

Pregnancy
Use only if potential benefit outweighs risk.
Lactation
Avoid unless essential

Price Intelligence

Rs 1,875.45
DRAP approved maximum price · per pack of 10 · approved 27 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 10Rs 1,875.45

Should you consider an alternative?

Other options containing Naloxone, and what they are not.

Identical active ingredient at the same strength. Cheapest per unit first.

Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.